Clindamycin Palmitate Hydrochloride

盐酸克林霉素棕榈酸酯

Report date: 2022/05/27 12:20:51
NME

Base Information

Drug NameClindamycin Palmitate Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial proteins inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsGram-Positive Bacterial Infections
Approved Indications in ChinaGram-Positive Bacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1986/04/07
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPku Healthcare Corp Ltd
Inactive CompaniesN/A
Active IndicationsGram-Positive Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeD10AF01G01AA10J01FF01
Related LinksKEGG